ANI Pharmaceuticals Inc. (ANIP)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q1 2026 | |||||
| ≡ | Polen Capital Management | Buy | 6,409 | 0.00 | |
| Q2 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 302.08% | 13,926 | 0.02 | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 4,610 | 0.01 | |
| Q4 2017 | |||||
| ≡ | Bill Miller - Miller Value Partners | Buy | 5,000 | 0.01 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.